retatrutide glp-1 retatrutide Unapproved weight loss drug retatrutide

What other health benefits do weight-loss drugs offer

Eligibility depends more on overall health status than age alone, which a clinician evaluates carefully

Despite promising Phase 2 results and an excellent safety profile, the compound could not demonstrate sufficient efficacy in the larger confirmatory trial to justify the investment required for continued pharmaceutical development toward regulatory approval

As featured in Microdose semaglutide delivers the same GLP-1 mechanism at a lower starting dose ideal for first-time patients who want to minimize side effects during ramp-up

Williams to share her thoughts and the facts